Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax in primary human glial cells

Journal of Virology

Volumn 81, Issue 4, 2007, Pages 1690-1700

  Banerjee, Prabal ^a   Rochford, Rosemary ^a   Antel, J ^b   Canute, G ^a   Wrzesinski, Stephen ^a   Sieburg, Michelle ^a   Feuer, Gerold ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LENTIVIRUS VECTOR; LYMPHOTOXIN; PROTEIN TAX1; PROTEIN TAX2; TAX PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM DISEASE; CHIMERA; CHRONIC INFLAMMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUSION; GENE INDUCTION; GENETIC TRANSCRIPTION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIOMA; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TAX1 GENE; TAX2 GENE; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

APOPTOSIS; CELL LINE; CYTOKINES; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; NEUROGLIA; PARAPARESIS, TROPICAL SPASTIC; TRANS-ACTIVATION (GENETICS); TRANSDUCTION, GENETIC;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; LENTIVIRUS;

EID: 33846810203     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01513-06     Document Type: Article

References (68)

1. Allan, S. M., and N. J. Rothwell. 2001. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2:734-744.
2. Araujo, A., and W. W. Hall. 2004. Human T-lymphotropic virus type II and neurological disease. Ann. Neurol. 56:10-19.
3. Aubert, C., M. Chamorro, and M. Brahic. 1987. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 3:319-326.
4. Basu, A., J. K. Krady, and S. W. Levison. 2004. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78:151-156.
5. Brack-Werner, R. 1999. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13:1-22.
6. Buchschacher, G. L., Jr., and F. Wong-Staal. 2000. Development of lentiviral vectors for gene therapy for human diseases. Blood 95:2499-2504.
7. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
8. Chlichlia, K., G. Moldenhauer, P. T. Daniel, M. Busslinger, L. Gazzolo, V. Schirrmacher, and K. Khazaie. 1995. Immediate effects of reversible HTLV-1 Tax function: T-cell activation and apoptosis. Oncogene 10:269-277.
9. Eller, J. L., S. L. Longo, D. J. Hicklin, and G. W. Canute. 2002. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme. Neurosurgery 51:1005-1014.
10. Eller, J. L., S. L. Longo, M. M. Kyle, D. Bassano, D. J. Hicklin, and G. W. Canute. 2005. Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo. Neurosurgery 56:155-162.
11. Endo, K., A. Hirata, K. Iwai, M. Sakurai, M. Fukushi, M. Oie, M. Higuchi, W. W. Hall, F. Gejyo, and M. Fujii. 2002. Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax. J. Virol. 76:2648-2653.
12. Eugenin, E. A., K. Osiecki, L. Lopez, H. Goldstein, T. M. Calderon, and J. W. Berman. 2006. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 26:1098-1106.
13. Fazakerley, J. K., and R. Walker. 2003. Virus demyelination. J. Neurovirol. 9:148-164.
14. Ferrari, C. C., A. M. Depino, F. Prada, N. Muraro, S. Campbell, O. Podhajcer, V. H. Perry, D. C. Anthony, and F. J. Pitossi. 2004. Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am. J. Pathol. 165:1827-1837.
15. Feuer, G., and P. L. Green. 2005. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24:5996-6004.
16. Giraudon, P., S. Buart, A. Bernard, and M. F. Belin. 1997. Cytokines secreted by glial cells infected with HTLV-1 modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes. Mol. Psychiatry 2:107-110, 84.
17. Giraudon, P., R. Szymocha, S. Buart, A. Bernard, L. Cartier, M. F. Belin, and H. Akaoka. 2000. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease. J. Immunol. 164:2718-2727.
18. Goetzl, E. J., M. J. Banda, and D. Leppert. 1996. Matrix metalloproteinases in immunity. J. Immunol. 156:1-4.
19. + T cells from young and old mice. J. Immunol. 150:3602-3614.
20. Ishihara, K., and T. Hirano. 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13:357-368.
21. Jiang, X. 2000. In vitro analysis of cell death of spinal oligodendrocytes in a rat model of HTLV-1 infection. Hokkaido Igaku Zasshi. 75:335-346.
22. Jiang, X., H. Ikeda, U. Tomaru, K. Morita, Y. Tanaka, and T. Yoshiki. 2000. A rat model for human T lymphocyte virus type I-associated myeloneuropathy: downregulation of bcl-2 expression and increase in sensitivity to TNF-alpha of the spinal oligodendrocytes. J. Neuroimmunol. 106:105-113.
23. Johnson, R. T. 1983. Evidence for polyomaviruses in human neurological diseases. Prog. Clin. Biol. Res. 105:183-190.
24. Kaplin, A. I., D. M. Deshpande, E. Scott, C. Krishnan, J. S. Carmen, I. Shats, T. Martinez, J. Drummond, S. Dike, M. Pletnikov, S. C. Keswani, T. H. Moran, C. A. Pardo, P. A. Calabresi, and D. A. Kerr. 2005. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J. Clin. Investig. 115:2731-2741.
25. Kasai, T., and K. T. Jeang. 2004. Two discrete events, human T-cell leukemia virus type I Tax oncoprotein expression and a separate stress stimulus, are required for induction of apoptosis in T cells. Retrovirology 1:7.
26. Konsman, J. P., S. Vigues, L. Mackerlova, A. Bristow, and A. Blomqvist. 2004. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 472:113-129.
27. + lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 53:23-29.
28. Kuroda, Y., M. Matsui, H. Takashima, and K. Kurohara. 1993. Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-1-associated myelopathy. J. Neuroimmunol. 45:133-136.
29. Lehky, T. J., E. P. Cowan, L. A. Lampson, and S. Jacobson. 1994. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J. Virol. 68:1854-1863.
30. Lehky, T. J., N. Flerlage, D. Katz, S. Houff, W. H. Hall, K. Ishii, C. Monken, S. Dhib-Jalbut, H. F. McFarland, and S. Jacobson. 1996. Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles. Ann. Neurol. 40:714-723.
31. Lehky, T. J., C. H. Fox, S. Koenig, M. C. Levin, N. Flerlage, S. Izumo, E. Sato, C. S. Raine, M. Osame, and S. Jacobson. 1995. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37:167-175.
32. Lemoine, F. J., S. Y. Kao, and S. J. Marriott. 2000. Suppression of DNA repair by HTLV type 1 Tax correlates with Tax trans-activation of proliferating cell nuclear antigen gene expression. AIDS Res. Hum. Retrovir. 16:1623-1627.
33. Lewis, M. J., N. Sheehy, M. Salemi, A. M. VanDamme, and W. W. Hall. 2002. Comparison of CREB- and NF-κB-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) tax proteins. Virology 295:182-189.
34. Mahieux, R., C. A. Pise-Masison, P. F. Lambert, C. Nicot, L. De Marchis, A. Gessain, P. Green, W. Hall, and J. N. Brady. 2000. Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 Tax to inhibit p53 function. J. Virol. 74:6866-6874.
35. Meertens, L., S. Chevalier, R. Weil, A. Gessain, and R. Mahieux. 2004. A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 Tax protein sequences is responsible for their divergent subcellular distribution. J. Biol. Chem. 279:43307-43320.
36. + HTLV-1-specific cytotoxic T cells. J. Virol. 71:9143-9149.
37. Mori, N., M. Fujii, G. Cheng, S. Ikeda, Y. Yamasaki, Y. Yamada, M. Tomonaga, and N. Yamamoto. 2001. Human T-cell leukemia virus type 1 tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T cells through nuclear factor-κB and c-AMP responsive element binding protein pathways. Virus Genes 22:279-287.
38. + T lymphocytes. Ann. Neurol. 40:84-90.
39. Nicot, C., R. Mahieux, S. Takemoto, and G. Franchini. 2000. Bcl-X(L) is upregulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood 96:275-281.
40. Nishimoto, N., K. Yoshizaki, N. Eiraku, K. Machigashira, H. Tagoh, A. Ogata, T. Kuritani, M. Osame, and T. Kishimoto. 1990. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Neurol. Sci. 97:183-193.
41. Ohya, O., U. Tomaru, I. Yamashita, T. Kasai, K. Morita, H. Ikeda, A. Wakisaka, and T. Yoshiki. 1997. HTLV-I induced myeloneuropathy in WKAH rats: apoptosis and local activation of the HTLV-I pX and TNF-alpha genes implicated in the pathogenesis. Leukemia 11(Suppl. 3):255-257.
42. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i:1031-1032.
43. Parra, B., D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman. 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162:1641-1647.
44. Perlman, S., and D. Ries. 1987. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb. Pathog. 3:309-314.
45. Prehn, J. H., C. Backhauss, and J. Krieglstein. 1993. Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cerebral Blood Flow Metab. 13:521-525.
46. Proescholdt, M. G., S. Chakravarty, J. A. Foster, S. B. Foti, E. M. Briley, and M. Herkenham. 2002. Intracerebroventricular but not intravenous interleukin-1β induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 112:731-749.
47. Pryce, G., D. Male, I. Campbell, and J. Greenwood. 1997. Factors controlling T-cell migration across rat cerebral endothelium in vitro. J. Neuroimmunol. 75:84-94.
48. Rochford, R., M. J. Cannon, R. E. Sabbe, K. Adusumilli, G. Picchio, J. M. Glynn, D. J. Noonan, D. E. Mosier, and M. V. Hobbs. 1997. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B-cell lines. Viral Immunol. 10:183-195.
49. Romero, I. A., M. C. Prevost, E. Perret, P. Adamson, J. Greenwood, P. O. Couraud, and S. Ozden. 2000. Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J. Virol. 74:6021-6030.
50. Semmes, O. J., F. Majone, C. Cantemir, L. Turchetto, B. Hjelle, and K. T. Jeang. 1996. HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs. Virology 217:373-379.
51. Sieburg, M., A. Tripp, J. W. Ma, and G. Feuer. 2004. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax oncoproteins modulate cell cycle progression and apoptosis. J. Virol. 78:10399-10409.
52. Simas, J. P., and J. K. Fazakerley. 1996. The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus. J. Gen. Virol. 77(Pt. 11):2701-2711.
53. Szymocha, R., H. Akaoka, C. Brisson, P. Beurton-Marduel, A. Chalon, A. Bernard, M. Didier-Bazes, M. F. Belin, and P. Giraudon. 2000. Astrocytic alterations induced by HTLV type 1-infected T lymphocytes: a role for Tax-1 and tumor necrosis factor alpha. AIDS Res. Hum. Retrovir. 16:1723-1729.
54. Szymocha, R., H. Akaoka, M. Dutuit, C. Malcus, M. Didier-Bazes, M. F. Belin, and P. Giraudon. 2000. Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J. Virol. 74:6433-6441.
55. Szymocha, R., C. Brisson, A. Bernard, H. Akaoka, M. F. Belin, and P. Giraudon. 2000. Long-term effects of HTLV-1 on brain astrocytes: sustained expression of Tax-1 associated with synthesis of inflammatory mediators. J. Neurovirol. 6:350-357.
56. Takenouchi, N., K. Yao, and S. Jacobson. 2004. Immunopathogenesis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches. Front. Biosci. 9:2527-2539.
57. Tendler, C. L., S. J. Greenberg, J. D. Burton, D. Danielpour, S. J. Kim, W. A. Blattner, A. Manns, and T. A. Waldmann. 1991. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell Biochem. 46:302-311.
58. Tomaru, U., H. Ikeda, X. Jiang, O. Ohya, and T. Yoshiki. 2003. Provirus expansion and deregulation of apoptosis-related genes in the spinal cord of a rat model for human T-lymphocyte virus type I-associated myeloneuropathy. J. Neurovirol. 9:530-538.
59. Torgeman, A., Z. Ben-Aroya, A. Grunspan, E. Zelin, E. Butovsky, M. Hallak, M. Lochelt, R. M. Flugel, E. Livneh, M. Wolfson, I. Kedar, and M. Aboud. 2001. Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I-infected T cells from apoptosis by the viral Tax protein. Exp. Cell Res. 271:169-179.
60. kip1 expression. J. Virol. 79:14069-14078.
61. + cells in vitro. J. Virol. 77:12152-12164.
62. Umehara, F., S. Izumo, M. Takeya, K. Takahashi, E. Sato, and M. Osame. 1996. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol. 91:343-350.
63. Watabe, K., T. Saida, and S. U. Kim. 1989. Human and simian glial cells infected by human T-lymphotropic virus type I in culture. J. Neuropathol. Exp. Neurol. 48:610-619.
64. Werb, Z., and J. R. Chin. 1998. Extracellular matrix remodeling during morphogenesis. Ann. N. Y. Acad. Sci. 857:110-118.
65. Wilson, K. C., D. M. Center, W. W. Cruikshank, and Y. Zhang. 2003. Binding of HTLV-1 tax oncoprotein to the precursor of interieukin-16, a T-cell PDZ domain-containing protein. Virology 306:60-67.
66. Wyss-Coray, T., E. Masliah, M. Mallory, L. McConlogue, K. Johnson-Wood, C. Lin, and L. Mucke. 1997. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature 389:603-606.
67. Yamada, T., S. Yamaoka, T. Goto, M. Nakai, Y. Tsujimoto, and M. Hatanaka. 1994. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J. Virol. 68:3374-3379.
68. Zhu, Y., B. Ahlemeyer, E. Bauerbach, and J. Krieglstein. 2001. TGF-β1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures. Neurochem. Int. 38:227-235.